References
- World Health Organisation. Burden of COPD. 2021. https://www.who.int/respiratory/copd/burden/en/.
- British Lung Foundation. Chronic Obstructive Pulmonary Disease (COPD) Statistics. 2021. [cited 2021 Jun 5]. Available from: https://statistics.blf.org.uk/copd.
- World Health Organisation. The Top 10 Causes of Death. 2020. [cited 2021 Jun 5]. Available from: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death.
- Smallwood N, Le B, Currow D, et al. Management of refractory breathlessness with morphine in patients with chronic obstructive pulmonary disease. Royal Aus Coll Physicians. 2015;45(9):898–904.
- Ekström M, Nilsson F, Abernethy AA, et al. Effects of opioids on breathlessness and exercise capacity in chronic obstructive pulmonary disease. A systematic review. Ann Am Thorac Soc. 2015;12(7):1079–1092. DOI:https://doi.org/10.1513/AnnalsATS.201501-034OC
- Uronis HE, Currow DC, Abernethy AP. Palliative management of refractory dyspnea in COPD. Int J Chron Obstruct Pulmon Dis. 2006;1(3):289–304. DOI:https://doi.org/10.2147/copd.2006.1.3.289
- Keogh E, Williams EM. Managing malnutrition in COPD: a review. Resp Med. 2021;176:106248. DOI:https://doi.org/10.1016/j.rmed.2020.106248
- Verberkt CA, van den Beuken-van Everdingen MHJ, Schols JMGA, et al. Effect of sustained-release morphine for refractory breathlessness in chronic obstructive pulmonary disease on health status: a randomized clinical trial. JAMA Intern Med. 2020;180(10):1306–1314. DOI:https://doi.org/10.1001/jamainternmed.2020.3134
- Currow D, Louw S, McCloud P, et al. Regular, sustained-release morphine for chronic breathlessness: a multicentre, double-blind, randomised, placebo-controlled trial. Thorax. 2020;75(1):50–56. DOI:https://doi.org/10.1136/thoraxjnl-2019-213681
- Barnes H, McDonald J, Smallwood N, et al. Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness. Cochrane Database Systematic Rev. 2016;3:CD011008
- Lanken PN, Terry PB, DeLisser HM, et al. An official american thoracic society clinical policy statement: palliative care for patients with respiratory diseases and critical illnesses. Am J Respir Crit Care Med. 2008;177(8):912–927. DOI:https://doi.org/10.1164/rccm.200605-587ST
- NICE. Palliative care – dyspnoea. 2020. https://cks.nice.org.uk/palliative-care-dyspnoea#!scenario:1.
- Janssen DJ, Spruit MA, Uszko-Lencer NH, et al. Symptoms, comorbidities, and healthcare in advanced chronic obstructive pulmonary disease or chronic heart failure. J Pall Care Med. 2011;14(6):735–743. DOI:https://doi.org/10.1089/jpm.2010.0479
- Rees C. Rapid research for nurses. Midwives, and health professionals. 2016. West Sussex: Wiley Blackwell, UK.
- Gerrish K and Lacey A. (eds.) 2010. The research process in nursing, 6th edn. Sussex, UK: Wiley-Blackwell.
- Bettany-Saltikov J, McSherry R. How to do a systematic literature review in nursing. 2nd ed. 2016. London: Open University Press, UK.
- Caldwell K, Henshaw L, Taylor G. Developing a framework for critiquing health research: an early evaluation. Nurse Ed Today. 2011;31:1–7.
- Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematicreviews and Meta-Analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097–6. DOI:https://doi.org/10.1371/journal.pmed.1000097
- Hadjiphilippou S, Odogwu SE, Dand P. Doctors’ attitudes towards prescribing opioids for refractory dyspnoea: a single-centred study. BMJ Support Palliat Care. 2014;4(2):190–192. DOI:https://doi.org/10.1136/bmjspcare-2013-000565
- Gaspar C, Alfarroba S, Telo L, et al. End-of-life care in COPD: a survey carried outwith Portuguese pulmonologists. Rev Port Pneum. 2014;20(3):123–130. DOI:https://doi.org/10.1016/j.rppneu.2014.01.008
- Crombie IK. The pocket guide to critical appraisal. 2nd ed. 1997. London: BMJ Publishing Group, UK.
- Janssen DJA, de Hosson SM, Bij de Vaate E, et al. Attitudes toward opioids forrefractory dyspnea in COPD among Dutch chest physicians. Chron Respir Dis. 2015;12(2):85–92.
- Ecenarro SP, Inchausti Iguiniz M, Tajada SP, Et al. Management of COPD in end-of-Life care by Spanish pulmonologists. COPD: J Chron Ob Pul Dis. 2018;15(2):171–176. DOI:https://doi.org/10.1080/15412555.2018.1441274
- Smallwood N, Currow D, Booth S, et al. Differing approaches to managing the chronic breathlessness syndrome in advanced COPD: a multi-national survey of specialists. COPD: J Chron Ob Pul Dis. 2018;15(3):294–302. DOI:https://doi.org/10.1080/15412555.2018.1502264
- Krajnik M, Hepgul N, Wilcock A, et al. Management of chronic breathlessness: amultinational survey of respiratory medicine and palliative care doctors. Eur Resp J. 2020;56(Suppl 64):5182.
- Carette H, Zysman M, Morelot-Panzini C, et al. Prevalence and management of chronic breathlessness in COPD in a tertiary care center. BMC Pulm Med. 2019;19(1):1–7. DOI:https://doi.org/10.1186/s12890-019-0851-5
- Young J, Donahue M, Rocker GM. Physicians’ attitudes to using opioids to treat dyspnea in advanced COPD: a qualitative study. Chest. 2010;138(4)Suppl. 483A. DOI:https://doi.org/10.1378/chest.10416
- Rocker G, Young J, Donahue M, et al. Perspectives of patients, family caregiversand physicians about the use of opioids for refractory dyspnea in advanced chronicobstructive pulmonary disease. Can Med Assoc J. 2012;184(9):497–504.
- Young J, Donahue M, Farquhar M. Using opioids to treat dyspnea in advance COPD attitudes and experiences of family physicians and respiratory therapists. Can Family Phys. 2012;58:401–407.
- Politis J, Eastman P, Le B, et al. Managing severe chronic breathlessness in chronic obstructive pulmonary disease is challenging for general practitioners. Am J Hosp Palliat Care. 2021;38(5):472–479. DOI:https://doi.org/10.1177/1049909120959061
- Global Initiative for Chronic Obstructive Lung Disease (GOLD). Pocket Guide to COPD diagnosis, management, and prevention’. 2020. www.goldcopd.org.
- NICE. Chronic obstructive pulmonary disease in over 16s: diagnosis andmanagement. 2018. www.nice.org/guidance/NG115.
- Mahler DA, Selecky PA, Harrod CG, et al. American college of chest Physicians consensus statement on the management of dyspnea in patients with advanced lung or heart disease. Chest. 2010;137(3):674–691. DOI:https://doi.org/10.1378/chest.09-1543
- Booth S, Johnson MJ. Improving the quality of life of people with advanced respiratory disease and severe breathlessness. Breathe (Sheff)). 2019;15(3):198–215. DOI:https://doi.org/10.1183/20734735.0200-2019
- Verberkt CA, van den Beuken-van Everdingen MHJ, Schols JMGA, et al. Respiratory adverse effects of opioids for breathlessness: a systematic review and Meta-analysis. Eur Resp J. 2017;50:1–18.
- Royal College of Nursing. RCN Fact Sheet, nurse prescribing in the UK. Poli Inter. 2014;1–7.